Search Local Studies

On this page you can search through all local studies (clinical trials) being conducted at the Indiana University - Purdue University Indianapolis. Please enter your search term(s) in the search box below, choose the appropriate checkbox and sorting options, and click the Search button.

If you are unable to locate a study for a specific disease/condition (or studies for healthy volunteers), please contact the CTSI at: (317) 278-2176.



Sign up here to receive information about research studies in Indiana!



IndianaCTSI Clinical Trials Search results for: 'prostate cancer'

Search Results:

Click on study title for more information about that study.

Bladder, Kidney, Prostate & Urinary Conditions (2)


1204008432 - A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to compare two methods of delivering high dose radiation to the prostate to see if the effects of the treatments are similar. 05-17-2012 No
1011003612 - A Multicenter Clinical Study of the Sonablate Age Range: 40 Years - 85 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to test a new treatment process for prostate cancer. 09-16-2011 No

Cancer (12)


See all studies related to 'prostate cancer' within Cancer

1212010175 - A Randomized Gene Fusion Stratified Phase 2 Trial Of Abiraterone With Or Without ABT 888 For Patients With Metastatic Castration-Resistant Prostate Cancer Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The researchers in this study will also look at whether the addition of ABT-888 to abiraterone with prednisone is better when compared to abiraterone and prednisone without ABT-888. 03-20-2014 No
1306011624 - Phase II Trial to Evaluate Benefit of Early Switch from first-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the opposite sequence, exploring molecular markers and mechanisms of taxane resistance in men with Metastatic Castration-Resistant Prost Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to evaluate the benefit of an early switch from docetaxel 75mg/m2 plus prednisone to cabazitaxel 25mg/m2 plus prednisone. 08-02-2013 No
1302010681 - A Randomized Phase II Study Evaluating OGX-427 in Patients with Metastatic Castrate-Resistant Prostate Cancer Who Have PSA Progression While Receiving Abiraterone Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this clinical research study is to determine if adding study drug OGX-427 to continuing abiraterone acetate and prednisone treatment will slow the progression of prostate cancer and decrease serum PSA values compared to continuing abiratero 04-02-2013 No
RTOG 0815 - A PHASE III PROSPECTIVE RANDOMIZED TRIAL OF DOSE-ESCALATED RADIOTHERAPY WITH OR WITHOUT SHORT-TERM ANDROGEN DEPRIVATION THERAPY FOR PATIENTS WITH INTERMEDIATE-RISK PROSTATE CANCER Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to show the advantages of an androgen deprivation therapy in patients with intermediate-risk prostate cancer. 08-13-2012 No
CTSU/CALBG 70807 - The Men's Age Range: 50 Years - 80 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to test whether or not telephone-based counseling changes the eating habits of men with prostate cancer. 08-13-2012 No

Men's Health (7)


See all studies related to 'prostate cancer' within Men's Health

1212010175 - A Randomized Gene Fusion Stratified Phase 2 Trial Of Abiraterone With Or Without ABT 888 For Patients With Metastatic Castration-Resistant Prostate Cancer Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The researchers in this study will also look at whether the addition of ABT-888 to abiraterone with prednisone is better when compared to abiraterone and prednisone without ABT-888. 03-20-2014 No
1306011624 - Phase II Trial to Evaluate Benefit of Early Switch from first-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the opposite sequence, exploring molecular markers and mechanisms of taxane resistance in men with Metastatic Castration-Resistant Prost Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to evaluate the benefit of an early switch from docetaxel 75mg/m2 plus prednisone to cabazitaxel 25mg/m2 plus prednisone. 08-02-2013 No
1302010681 - A Randomized Phase II Study Evaluating OGX-427 in Patients with Metastatic Castrate-Resistant Prostate Cancer Who Have PSA Progression While Receiving Abiraterone Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this clinical research study is to determine if adding study drug OGX-427 to continuing abiraterone acetate and prednisone treatment will slow the progression of prostate cancer and decrease serum PSA values compared to continuing abiratero 04-02-2013 No
RTOG 0815 - A PHASE III PROSPECTIVE RANDOMIZED TRIAL OF DOSE-ESCALATED RADIOTHERAPY WITH OR WITHOUT SHORT-TERM ANDROGEN DEPRIVATION THERAPY FOR PATIENTS WITH INTERMEDIATE-RISK PROSTATE CANCER Age Range: 18 Years - 100 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to show the advantages of an androgen deprivation therapy in patients with intermediate-risk prostate cancer. 08-13-2012 No
CTSU/CALBG 70807 - The Men's Age Range: 50 Years - 80 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to test whether or not telephone-based counseling changes the eating habits of men with prostate cancer. 08-13-2012 No

Nutrition (1)


CTSU/CALBG 70807 - The Men's Age Range: 50 Years - 80 Years,
Races: All,
Ethnicities: All
Prostate Cancer The purpose of this study is to test whether or not telephone-based counseling changes the eating habits of men with prostate cancer. 08-13-2012 No

+ Semantic Tags (What's this?)